Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Long-Acting Cabotegravir/Rilpivirine for Thai Youth Living with HIV
TCTR20250316001Completed
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of cabotegravir and rilpivirine in human immunodeficiency virus infection (HIV), sponsored by none. Started Aug 2024; status: completed.
02
Drugs
cabotegravirrilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20250316001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250316001.